Gilead Sciences (GILD) PT Lowered to $105 at Oppenheimer, 'continue to be bullish on the name' despite weaker Q4 sales
Tweet Send to a Friend
(Updated - February 12, 2024 6:33 AM EST)
Oppenheimer analyst Hartaj Singh lowered the price target on Gilead Sciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Hartaj Singh lowered the price target on Gilead Sciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
